Companies Attending VIVE Event 2025

Declaration Partners is a private investment firm that seeks to be a value-added capital partner and strategic resource to founders & entrepreneurs, management teams, and asset owners. Anchored by the family office of private equity veteran and philanthropist David M. Rubenstein, Declaration invests on behalf of family offices and like-minded institutional investors. Declaration’s approach emphasizes partnership born from its family office heritage while seeking to achieve favorable long-term outcomes with strong alignment. Declaration has approximately $2.1 billion in assets under management across its private investment strategies, which include tactical growth equity, real estate, seeding, and other opportunistic strategies. The firm was founded in 2017 and is headquartered in New York with an office in the Washington, DC area.

Operator of a medicine analytics company intended to deliver accurate, predictive insights to fuel proactive management of disease risk and health outcomes. The company platform leverages deep know-how and support across multi-omics, clinical data, social determinants of health, and other healthcare data sources to de-risk R&D and deliver actionable insights and results quickly, it provides accurate and scalable data to leverage genomics, clinical data, and other healthcare sources to provide quick insights and include biomarker discovery, RNA diagnostics, and population health analytics to improve patient outcomes and reduce costs and helps partners to establish repeatable innovation programs with a focus on chronic diseases such as multiple sclerosis, IBD, diabetes, COPD, CKD, and cancer, thereby improving health equity by giving healthcare companies access to technology to decode unrecognized patterns of disease risk and tackle complex health care problems.

Decoded Health provides a clinical hyperautomation platform that combines explainable ML with human-in-the-loop task autonomy to automate patient conversations and augment physicians' clinical workflows. Decoded Health's platform automates clinical tasks, allowing physicians to manage a panel of over 8,000 patients instead of 2,000, improving population health and deepening the physician-patient relationship.

Developer of a clinical and administrative software intended for hospitals and laboratories in the public and private sectors. The company's software offers healthcare information, diagnostic, radiology, cardiology and business intelligence software, enabling clients to effectively implement their strategies.

Deep 6 AI is a computer software company that utilizes an AI-based platform that finds patients for clinical trials and it helps to provide cure to people. Its platform specializes in analyzing structured data, such as ICD-10 codes, unstructured clinical data, doctor’s notes, pathology reports, and operating notes.

Deepgram's voice AI platform provides APIs for speech-to-text, text-to-speech, and language understanding. From medical transcription to autonomous agents, Deepgram is the go-to choice for developers of voice AI experiences.

Developer of an online medical platform designed to connect doctors with patients. The company's platform utilizes machine learning to match suitable doctors and connects them with patients in need, enabling patients to get proper treatment in time.

Developer of an artificial intelligence-based medical scribe technology designed to automate medical documentation. The company's technology extracts medically relevant information that summarizes the interaction into cohesive sentences and directly integrates notes into the appropriate fields in EHR, enabling healthcare providers to focus on delivering face-to-face care to their patients.

Deerfield Academy, founded in 1797, is an independent, coeducational boarding and day school located in Western Massachusetts.

Operator of a medtech incubator intended to support and advance innovation into commercial products and enterprises. The company's platform provides a variety of features, including funding and resources for early-stage medtech companies, a network of experts in medtech, and support for regulatory and clinical trials, enabling early-stage medtech companies to develop transformational products to improve patient outcomes and streamline care.